Phase II/III therapeutic trial to study the safety and efficacy of the novel application of an FDA-approved drug to reduce neurotoxin levels and improve neurologic outcome in SAH patients

  • Hwang, Brian (PI)

Projet

Détails sur le projet

StatutTerminé
Date de début/de fin réelle1/1/09 → 1/1/10

Financement

    Keywords

    • Neurología clínica
    • Neurología
    • Medicina (todo)
    • Neurociencia (todo)
    • Bioquímica, genética y biología molecular (todo)